Direkt zum Inhalt
Merck
  • Method development for impurity profiling in SFC: The selection of a dissimilar set of stationary phases.

Method development for impurity profiling in SFC: The selection of a dissimilar set of stationary phases.

Journal of pharmaceutical and biomedical analysis (2015-01-30)
Charlene Galea, Debby Mangelings, Yvan Vander Heyden
ZUSAMMENFASSUNG

Supercritical fluid chromatography (SFC) is drawing considerable interest as separation technique in the pharmaceutical industry. The technique is already well established in chiral separations both analytically and on a preparative scale. The use of SFC as a technique for drug impurity profiling is examined here. To define starting conditions in method development for drug impurity profiling, a set of dissimilar stationary phases is screened in parallel. The possibility to select a set of dissimilar columns using the retention factors (k-values) for a set of 64 drugs measured on 27 columns in SFC was examined. Experiments were carried out at a back-pressure of 150 bar and 25 °C with a mobile phase consisting of CO2 and methanol with 0.1% isopropylamine (5-40% over 10 min) at a flow rate of 3 mL/min. These k-values were then used to calculate correlation coefficients on the one hand and to perform a principal component analysis on the other. The Kennard and Stone algorithm, besides dendrograms and correlation-coefficient colour maps were used to select a set of 6 dissimilar stationary phases. The stationary phase characterization results from this study were compared to those from previous studies found in the literature. Retention mechanisms for compounds possessing different properties were also evaluated. The dissimilarity of the selected subset of 6 stationary phases was validated using mixtures of compounds with similar properties and structures, as one can expect in a drug impurity profile.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Dopamin -hydrochlorid
Sigma-Aldrich
Salzsäure -Lösung, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
Salzsäure, 36.5-38.0%, BioReagent, for molecular biology
Sigma-Aldrich
Phenol -Lösung, BioReagent, Equilibrated with 10 mM Tris HCl, pH 8.0, 1 mM EDTA, for molecular biology
Supelco
Salzsäure -Lösung, volumetric, 0.1 M HCl (0.1N), endotoxin free
Sigma-Aldrich
Isopropylalkohol, ≥99.7%, FCC, FG
Sigma-Aldrich
Acetylsalicylsäure, ≥99.0%
Sigma-Aldrich
Isopropylamin, ≥99.5%
Sigma-Aldrich
2-Propanol, for molecular biology, BioReagent, ≥99.5%
Sigma-Aldrich
Methanol, anhydrous, 99.8%
Sigma-Aldrich
2-Propanol, BioUltra, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
Benzylamin, ReagentPlus®, 99%
Sigma-Aldrich
2-Propanol, anhydrous, 99.5%
Sigma-Aldrich
Phenol -Lösung, BioReagent, Saturated with 0.01 M citrate buffer, pH 4.3 ± 0.2, for molecular biology
Sigma-Aldrich
2-Propanol, electronic grade, 99.999% trace metals basis
Sigma-Aldrich
Phenol, ≥99%
Sigma-Aldrich
Chlorwasserstoff, ReagentPlus®, ≥99%
Sigma-Aldrich
Diclofenac Natriumsalz
Sigma-Aldrich
Aspirin, meets USP testing specifications
Sigma-Aldrich
1,1-Dimethyl-biguanid -hydrochlorid, 97%
Sigma-Aldrich
Salicylsäure, ACS reagent, ≥99.0%
Sigma-Aldrich
Salzsäure -Lösung, ~6 M in H2O, for amino acid analysis
Sigma-Aldrich
Carbamazepin, powder
Sigma-Aldrich
Phenol, puriss. p.a., ACS reagent, reag. Ph. Eur., 99.0-100.5%
Sigma-Aldrich
Procain -hydrochlorid, ≥97%
Sigma-Aldrich
Chlorwasserstoff -Lösung, 3 M in cyclopentyl methyl ether (CPME)
Sigma-Aldrich
Prazosin -hydrochlorid, ≥99.0% (HPLC)
Sigma-Aldrich
Phenol, natural, 97%, FG
Sigma-Aldrich
Diphenhydramin -hydrochlorid, ≥98% (HPLC)
Sigma-Aldrich
Salzsäure -Lösung, 32 wt. % in H2O, FCC